Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

David Geldmacher

ResearcherPublications, citations & collaboration network

David Geldmacher is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 282 works, 15,195 citations, an h-index of 56 and an i10-index of 146.

282
Works
15,195
Citations
56
h-index
146
i10-index

How has David Geldmacher's publication output changed over time?

ScholarIQpublication output · 1997–2019

Output declined50% over the shown period — from 2 works in 1997 to 1 in 2019.

2
1
2
1
1
1
199719982001200320062019

What are the most-cited papers on David Geldmacher?

ScholarIQmost cited works
Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
Richard C. Mohs, David S. Knopman, Ronald C. Petersen, Steven H. Ferris, Chris Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Chris M. Clark, Leon J. Thal
Alzheimer Disease & Associated Disorders. 1997708 Citations
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Yanxu Yang, David Geldmacher, Karl Herrup
Journal of Neuroscience. 2001625 CitationsOPEN ACCESS
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Jonathan C. Busser, David Geldmacher, Karl Herrup
Journal of Neuroscience. 1998555 CitationsOPEN ACCESS
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
Richard C. Mohs, David S. Knopman, R. Petersen, Steven H. Ferris, Christopher Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Camilla N. Clark, L. J. Thal
PubMed. 1997494 Citations
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
Garam Lee, Kwangsik Nho, Byungkon Kang, Kyung-Ah Sohn, Dokyoon Kim, for Alzheimer’s Disease Neuroimaging Initiative, Michael W. Weiner, Paul Aisen, Ronald Petersen, Clifford R. Jack, William J. Jagust, John Q. Trojanowki, Arthur W. Toga, Laurel Beckett, Robert C. Green, Andrew J. Saykin, John C. Morris, Leslie M. Shaw, Zaven S. Khachaturian, Greg Sorensen, María C. Carrillo, Lew Kuller, Marc Raichle, Steven M. Paul, Peter J. Davies, Howard Fillit, Franz Hefti, Davie Holtzman, Marek-Marsel Mesulam, William Z. Potter, Peter J. Snyder, Tom Montine, Ronald G. Thomas, Michael Donohue, Sarah Walter, Tamie Sather, Gus Jiminez, Archana B. Balasubramanian, Jennifer Mason, Iris Sim, Danielle Harvey, Matt A. Bernstein, Nick C. Fox, Paul M. Thompson, Norbert Schuff, Charles DeCarli, Bret Borowski, Jeff Gunter, Matthew L. Senjem, Prashanthi Vemuri, David Jones, Kejal Kantarci, Chad Ward, Robert A. Koeppe, Norm Foster, Eric M. Reiman, Kewei Chen, Chet Mathis, Susan Landau, Nigel J. Cairns, Erin Householder, Lisa Taylor‐Reinwald, Virginia Lee, Magdalena Korecka, Michal Figurski, Karen Crawford, Scott Neu, Tatiana M. Foroud, Steven Potkin, Li Shen, Kelley Faber, Sungeun Kim, Lean Tha, Richard Frank, John Hsiao, Jeffrey Kaye, Joseph F. Quinn, Lisa C. Silbert, Betty Lind, Raina Carter, Sara Dolen, Beau M. Ances, Maria Carroll, Mary L. Creech, Erin Franklin, Mark A. Mintun, Stacy Schneider, Angela Oliver, Lon S. Schneider, Sonia Pawluczyk, Mauricio Beccera, Liberty Teodoro, Bryan M. Spann, James Brewer, Helen Vanderswag, Adam Fleisher, Daniel Marson, Randall Griffith, David Clark, David Geldmacher
Scientific Reports. 2019407 CitationsOPEN ACCESS

Related on ScholarIQ

University of Alabama at Birmingham
Institution
Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs
Paper
DNA Replication Precedes Neuronal Cell Death in Alzheimer's Disease
Paper
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Paper
Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.
Paper
Predicting Alzheimer’s disease progression using multi-modal deep learning approach
Paper
470M+ articles · free account